Compounded Semaglutide Cost: What Drives the Price and What It Covers

You have been researching compounded semaglutide, and the price variation online is confusing. Some monthly prices look low, others several times higher. Some mention labs, some do not. Here is what drives the cost of compounded semaglutide, what a monthly fee may or may not include, and how to compare programs on total cost.

What to check before using compounded semaglutide

Transformation Health does not sell medication or set prices. Prices vary by program and dose. We plan to publish current market prices with sources and capture dates; until then, use the factors below to compare what programs quote you.

• Dose. Many programs charge more as the dose increases. A starting-dose price is not the price you will pay at a maintenance dose.
• Concentration and form. Compounded semaglutide comes in different concentrations and in injectable and oral forms, and the price can differ by form.
• What the fee includes. Some fees bundle medication, provider visits, and follow-up. Others cover the medication only.
• Lab work. Some programs include required labs; others bill them separately or ask you to get them through your own provider.
• Shipping and supplies. Check whether shipping, syringes, needles, and sharps containers are included.
• Membership and cancellation terms. Look for separate membership fees, minimum commitments, prepay requirements, and how cancellation works.

What is included (and what is not)

There is no standard bundle. When you compare programs, look for each of these line items and note whether it is included, billed separately, or not offered.

The medication. Compounded semaglutide is prepared by a state-licensed compounding pharmacy and, at most telehealth programs, shipped to you. Injectable formulations are usually used once weekly. Oral formulations are usually taken daily. Ask which pharmacy prepares it.

Lab work. Some programs require blood work before or during treatment. Ask whether it is included, where it is drawn, and whether it is billed to you or your insurance.

Provider care. At most telehealth programs, a licensed provider reviews your health history and current medications, decides whether a prescription is appropriate, and follows up during treatment. Ask whether follow-up visits cost extra.

Coaching or nutrition support. Some programs include nutrition or lifestyle coaching; many do not. If it matters to you, ask what it involves and whether it costs extra.

What is usually not included. Telehealth programs generally do not cover other healthcare services, such as primary care or specialist visits. If a provider decides you need additional evaluation before starting, that visit is usually billed separately.

Program options to review

Compounded semaglutide is offered by different programs in injectable and oral forms. Compare them on the same basis: form, dose, and what the fee covers.

Transformation Health does not accept payment from providers. How we make money.

Regulatory status and compounding availability

Compounded semaglutide exists within a specific legal framework, and its status has changed.

Shortage status. On February 21, 2025, the FDA determined that the shortage of semaglutide injection products was resolved^[1]. While a drug is on the shortage list, compounders have more room to prepare copies of it.

What FDA said about compounders. The FDA said it would not take action against state-licensed 503A pharmacies for compounding semaglutide products that are essentially copies of approved products until April 22, 2025, and against 503B outsourcing facilities until May 22, 2025. After an April 24, 2025 court decision denied a preliminary injunction in Outsourcing Facilities Association v. FDA, the FDA stated that the 503A period had ended^[1]. The FDA has posted later updates to this policy, most recently dated April 1, 2026; check the FDA page for the current statement^[1].

What this means for you. Compounded semaglutide is still offered by some telehealth programs, but availability depends on federal and state law and FDA action, and it can change. If you are planning longer-term treatment, ask the provider you choose what would happen if the compounded option became unavailable, and what brand-name options (through insurance or manufacturer programs) would cost you.

Brand-name semaglutide pricing for comparison

Brand-name semaglutide (Wegovy for weight management, Ozempic for type 2 diabetes) is FDA-approved and generally costs more than compounded semaglutide when paid out of pocket. Manufacturer self-pay programs and insurance coverage can change what you pay. We plan to publish current brand-name self-pay prices from the manufacturers’ own pages, with capture dates.

If you have insurance, coverage for weight management medications is inconsistent. Many plans exclude weight loss medications, and plans that cover them often require prior authorization, which can take time.

A lower price for compounded semaglutide reflects the different production model, not clinical equivalence. Compounded semaglutide is not FDA-approved and is not the same product as Wegovy or Ozempic. It may differ in formulation, purity, and potency.

Why you see such different prices online

If you have been comparing programs, you have noticed wide price variation. Here is why.

Hidden cost structures. Some programs advertise a low monthly price but bill lab work, provider visits, or a membership separately. Once those are added, the total can be much higher than the headline price.

Dose-based pricing. Some programs quote the starting-dose price. If the price rises as the dose increases, your monthly cost later in treatment can be higher.

Unclear what is included. When a website does not list what the monthly fee covers, ask before you assume it covers everything.

Programs without labs or monitoring. If a program offers semaglutide without asking about your health history or offering follow-up with a licensed provider, ask how it monitors side effects. Ongoing provider oversight is part of using a prescription medication.

Prepay discounts. Some programs offer a lower per-month price for paying several months up front. Check the refund and cancellation terms before you prepay.

When evaluating any program, ask directly:

• Does the monthly price include medication, and at which dose?
• Does the price change as the dose increases?
• Does it include lab work?
• Does it include ongoing provider visits?
• Does it include shipping and supplies?
• Are there membership fees, minimum commitments, or cancellation charges?

If a program will not answer these questions clearly, keep looking.

Transformation Health does not accept payment from providers. How we make money.

How the process should work

Eligibility

A licensed provider decides whether semaglutide is appropriate based on your health history. Programs set their own criteria.

BMI criteria. Many programs use criteria similar to those in the brand-name semaglutide trials. The STEP 1 trial, for example, enrolled adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition^[2].

Health history. The provider will review your current medications, medical conditions, and any reasons GLP-1 medication may not be appropriate for you.

A provider may decide it is not appropriate. Even if your BMI meets a program’s threshold, a provider may decide semaglutide is not right for your health situation.

How compounded semaglutide works

Semaglutide is a GLP-1 receptor agonist^[2]. It reduces appetite and slows the rate at which your stomach empties. For many people, that makes it easier to change eating habits.

Semaglutide has risks as well as benefits. On the FDA label for brand-name semaglutide (Wegovy), the most common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain, and the label carries a boxed warning about thyroid C-cell tumors^[3]. Compounded semaglutide has not been evaluated by the FDA, so label information describes the brand-name product studied.

Whether to continue, adjust, or stop the medication over time is a decision to make with your prescriber.

Important disclosures

This content is for general education and is not medical advice. Talk with a licensed provider about your situation.

Compounded semaglutide is not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed^[4]. Compounded semaglutide contains semaglutide, but it is not the same as brand-name semaglutide, which went through FDA review, and it may differ in formulation, purity, and potency. You cannot assume the two will produce the same results.

Regulatory status is subject to change. Compounding of semaglutide depends on federal and state pharmacy law and on FDA policy, which has changed since semaglutide left the shortage list in February 2025^[1]. Availability cannot be guaranteed.

Results vary. Weight loss is not guaranteed and depends on many factors, including your starting weight, age, metabolism, adherence to the medication, eating habits, activity, sleep, and overall health. Trial results describe study participants and are not a prediction for any individual.

Citations

[1] U.S. Food and Drug Administration. “FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.” Content current as of 04/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize (Accessed 2026-10-16.)

[2] Wilding JPH, Batterham RL, Calanna S, et al. “Once-weekly semaglutide in adults with overweight or obesity.” NEJM. 2021. https://pubmed.ncbi.nlm.nih.gov/33567185/

[3] U.S. Food and Drug Administration. WEGOVY (semaglutide) injection and tablets, prescribing information, Boxed Warning and section 6. Revised 06/2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s025lbl.pdf

[4] U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” Content current as of 10/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss (Accessed 2026-10-16.)